Status:
Ready to upload
Record number:
1634
Adverse Occurrence type:
MPHO Type:
Estimated frequency:
Frequency of passenger lymphocyte syndrome = 56% of recipients of ABO-unmatched liver transplants; DHTR frequency = 0.66% of transfusion patients; frequency of both approximately 4 per 1000 recipients of ABO-unmatched liver transplants who receive multiple RBC transfusions.
Time to detection:
16 days
Alerting signals, symptoms, evidence of occurrence:
Hemoglobinemia, hyperbilirubinemia, increased RBC transfusion requirement.
Demonstration of imputability or root cause:
Anti-A related to passenger lymphocyte syndrome since recipient was group A; anti-E (recipient E-negative) related to DHTR (recipient lymphocytes making allo-antibody despite immunosuppressive treatment). Evidence of DHTR inferred rather than proven directly.
Imputability grade:
2 Probable
Groups audience:
Keywords:
Suggest new keywords:
passenger lymphocyte syndrome, delayed hemolytic transfusion reaction
Suggest references:
Jacobs, LB, Shirey, RS and Ness, PM. (1996). Hemolysis due to the simultaneous occurrence of passenger lymphocyte syndrome and a delayed hemolytic transfusion reaction in a liver transplant patient. Arch Pathol Lab Med 120:684-6
Note:
First report of simultaneous occurrence of DHTR and passenger lymphocyte syndrome
Expert comments for publication:
First report of simultaneous occurrence of both delayed hemolytic transfusion reaction and passenger lymphocyte syndrome (lymphocytes in the donor organ reacting against recipient RBCs) in a liver transplant recipient.